Suppr超能文献

用于原发性纤毛运动障碍研究的下呼吸道临床结局指标:一项范围综述

Lower airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review.

作者信息

Gahleitner Florian, Thompson James, Jackson Claire L, Hueppe Jana F, Behan Laura, Dehlink Eleonora, Goutaki Myrofora, Halbeisen Florian, Queiroz Ana Paula L, Thouvenin Guillaume, Kuehni Claudia E, Latzin Philipp, Lucas Jane S, Rubbo Bruna

机构信息

Primary Ciliary Dyskinesia Centre, NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Paediatric Respiratory Medicine, Royal Hospital for Children and Young People, Edinburgh, UK.

出版信息

ERJ Open Res. 2021 Nov 29;7(4). doi: 10.1183/23120541.00320-2021. eCollection 2021 Oct.

Abstract

OBJECTIVES

Disease-specific, well-defined and validated clinical outcome measures are essential in designing research studies. Poorly defined outcome measures hamper pooling of data and comparisons between studies. We aimed to identify and describe pulmonary outcome measures that could be used for follow-up of patients with primary ciliary dyskinesia (PCD).

METHODS

We conducted a scoping review by systematically searching MEDLINE, Embase and the Cochrane Database of Systematic Reviews online databases for studies published from 1996 to 2020 that included ≥10 PCD adult and/or paediatric patients.

RESULTS

We included 102 studies (7289 patients). 83 studies reported on spirometry, 11 on body plethysmography, 15 on multiple-breath washout, 36 on high-resolution computed tomography (HRCT), 57 on microbiology and 17 on health-related quality of life. Measurement and reporting of outcomes varied considerably between studies ( different scoring systems for chest HRCT scans). Additionally, definitions of outcome measures varied ( definition of chronic colonisation by respiratory pathogen), impeding direct comparisons of results.

CONCLUSIONS

This review highlights the need for standardisation of measurements and reporting of outcome measures to enable comparisons between studies. Defining a core set of clinical outcome measures is necessary to ensure reproducibility of results and for use in future trials and prospective cohorts.

摘要

目的

特定疾病、定义明确且经过验证的临床结局指标对于设计研究至关重要。定义不明确的结局指标会妨碍数据汇总及研究间的比较。我们旨在识别并描述可用于原发性纤毛运动障碍(PCD)患者随访的肺部结局指标。

方法

我们进行了一项范围综述,通过系统检索MEDLINE、Embase和Cochrane系统评价数据库在线数据库,查找1996年至2020年发表的纳入≥10例PCD成年和/或儿科患者的研究。

结果

我们纳入了102项研究(7289例患者)。83项研究报告了肺功能测定,11项报告了体容积描记法,15项报告了多次呼吸冲洗法,36项报告了高分辨率计算机断层扫描(HRCT),57项报告了微生物学,17项报告了健康相关生活质量。研究间结局的测量和报告差异很大(胸部HRCT扫描的评分系统不同)。此外,结局指标的定义也有所不同(呼吸道病原体慢性定植的定义),这妨碍了结果的直接比较。

结论

本综述强调了对结局指标的测量和报告进行标准化的必要性,以便能够进行研究间的比较。定义一组核心临床结局指标对于确保结果的可重复性以及用于未来试验和前瞻性队列研究是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00b7/8628193/1fbdb18b56a7/00320-2021.01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验